| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 256.467 | 232.490 | 322.878 | 329.202 | 300.473 | 314.027 | 310.022 | 284.765 | 320.599 | 327.078 |
| Total Income - EUR | 273.400 | 327.051 | 546.177 | 510.285 | 507.969 | 464.331 | 463.300 | 429.397 | 454.484 | 477.534 |
| Total Expenses - EUR | 203.886 | 251.124 | 403.540 | 421.443 | 413.902 | 418.922 | 411.989 | 465.488 | 428.305 | 449.373 |
| Gross Profit/Loss - EUR | 69.514 | 75.927 | 142.637 | 88.842 | 94.067 | 45.409 | 51.311 | -36.092 | 26.178 | 28.161 |
| Net Profit/Loss - EUR | 69.514 | 75.927 | 131.544 | 84.613 | 90.140 | 42.260 | 48.196 | -38.970 | 22.970 | 23.314 |
| Employees | 7 | 5 | 9 | 0 | 9 | 8 | 8 | 8 | 6 | 6 |
Check the financial reports for the company - Novalact Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 230.873 | 215.837 | 263.519 | 274.413 | 271.094 | 274.108 | 247.973 | 214.913 | 195.884 | 202.011 |
| Current Assets | 48.160 | 78.872 | 74.890 | 55.632 | 82.144 | 82.885 | 85.803 | 96.267 | 89.563 | 104.319 |
| Inventories | 19.910 | 40.007 | 37.977 | 21.053 | 32.705 | 26.120 | 25.289 | 44.607 | 29.616 | 29.062 |
| Receivables | 30.436 | 35.229 | 34.050 | 31.975 | 46.513 | 46.359 | 44.109 | 47.152 | 49.970 | 72.860 |
| Cash | -2.185 | 3.636 | 2.862 | 2.604 | 2.926 | 10.406 | 16.404 | 4.508 | 9.976 | 2.397 |
| Shareholders Funds | -129.195 | -51.951 | 80.472 | 157.161 | 209.487 | 191.957 | 190.412 | 39.491 | 62.341 | 71.700 |
| Social Capital | 1.350 | 1.336 | 1.313 | 1.289 | 1.264 | 1.240 | 1.213 | 1.217 | 1.213 | 1.206 |
| Debts | 408.228 | 346.660 | 257.937 | 172.884 | 143.852 | 165.104 | 143.443 | 269.870 | 222.211 | 234.293 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.900 | 975 | 337 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "145 - 145" | |||||||||
| CAEN Financial Year |
145
|
|||||||||
Comments - Novalact Srl